https://www.pharmexec.com/view/daily-eli-lilly-acquires-engage-bio2026-05-20T19:57:19.175Z2026-05-20T19:57:19.175Z https://www.pharmexec.com/view/eli-lilly-202-million-agreement-acquire-engage-bio2026-05-20T16:07:55.626Z2026-05-20T16:07:55.626Z https://www.pharmexec.com/view/targeting-hpv-hidden-mechanism-qa-sandra-coufal2026-05-20T13:45:00Z2026-05-20T13:45:00Z https://www.pharmexec.com/view/roundup-bristol-myers-squibb-strategic-agreement-anthropic-incyte-genesis-expand-strategic-collaboration2026-05-20T13:29:11.257Z2026-05-20T13:29:11.257Z https://www.pharmexec.com/view/positioning-tgn-s15-keytruda-combination-partner2026-05-20T10:00:00Z2026-05-20T10:00:00Z https://www.pharmexec.com/view/industry-communication-engagement-fda2026-05-20T10:00:00Z2026-05-20T10:00:00Z https://www.pharmexec.com/view/difference-between-real-time-clinical-data-review-clinical-trial-oversite2026-05-20T10:00:00Z2026-05-20T10:00:00Z https://www.pharmexec.com/view/daily-trumprx-expands-offer-over-600-generic-drugs2026-05-19T16:41:56.082Z2026-05-19T16:41:56.082Z https://www.pharmexec.com/view/inside-expert-network-guiding-tgn-s15-market2026-05-19T16:25:00Z2026-05-19T16:25:00Z https://www.pharmexec.com/view/trumprx-expands-offer-generic-medications2026-05-19T16:16:52.286Z2026-05-19T16:16:52.286Z https://www.pharmexec.com/view/rethinking-pharma-s-go-to-market-formula2026-05-19T15:00:00Z2026-05-19T15:00:00Z https://www.pharmexec.com/view/funding-roundup-violet-therapeutics-4-million-seed-extension-full-life-technologies-financing2026-05-19T13:20:55.845Z2026-05-19T13:20:55.845Z https://www.pharmexec.com/view/risks-benefits-fda-reviewing-real-time-data2026-05-19T10:00:00Z2026-05-19T10:00:00Z https://www.pharmexec.com/view/investors-should-expect-current-regulatory-environment2026-05-19T10:00:00Z2026-05-19T10:00:00Z https://www.pharmexec.com/view/daily-fda-approves-baxdrostat2026-05-18T18:01:20.140Z2026-05-18T18:01:20.140Z https://www.pharmexec.com/view/fda-leadership-overhaul-commissioner-makary-departure-report2026-05-18T15:15:20.379Z2026-05-18T15:15:20.379Z https://www.pharmexec.com/view/fda-baxdrostat-uncontrolled-hypertension2026-05-18T14:59:15.657Z2026-05-18T14:59:15.657Z https://www.pharmexec.com/view/regeneron-2-billion-collaboration-parabilis-medicines-discover-develop-therapeutic-candidates2026-05-18T13:41:31.693Z2026-05-18T13:41:31.693Z https://www.pharmexec.com/view/fda-trastuzumab-deruxtecan-early-her2-positive-breast-cancer2026-05-18T13:11:58.034Z2026-05-18T13:11:58.034Z https://www.pharmexec.com/view/-gates-foundation-perfectly-aligned-interests2026-05-18T10:00:00Z2026-05-18T10:00:00Z https://www.pharmexec.com/view/fda-new-pilot-program-real-time-review-clinical-data2026-05-18T10:00:00Z2026-05-18T10:00:00Z https://www.pharmexec.com/view/politics-capital-markets-misinformation-impact-biotech-jeremy-levin2026-05-18T10:00:00Z2026-05-18T10:00:00Z https://www.pharmexec.com/view/adjusting-strategies-changing-dynamics-fda2026-05-18T10:00:00Z2026-05-18T10:00:00Z https://www.pharmexec.com/view/daily-fda-approves-astrazeneca-fasenra2026-05-15T18:15:33.455Z2026-05-15T18:15:33.455Z https://www.pharmexec.com/view/pharmaceutical-executive-may-2026-interactive-digital-edition2026-05-15T17:10:00Z2026-05-15T17:10:00Z https://www.pharmexec.com/view/model-examples2026-05-15T17:00:00Z2026-05-15T17:00:00Z https://www.pharmexec.com/view/john-oyler-rewiring-operations-in-oncology2026-05-15T15:00:00Z2026-05-15T15:00:00Z https://www.pharmexec.com/view/fda-places-full-clinical-hold-aardvark-therapeutics-ard-1012026-05-15T13:56:29.245Z2026-05-15T13:56:29.245Z https://www.pharmexec.com/view/fda-approves-fasenra-hypereosinophilic-syndrome2026-05-15T13:17:54.939Z2026-05-15T13:17:54.939Z https://www.pharmexec.com/view/relationship-between-capital-markets-biotech2026-05-15T12:46:11.194Z2026-05-15T12:46:11.194Z https://www.pharmexec.com/view/women-health-investment-rhetoric-vs-reality2026-05-15T10:00:00Z2026-05-15T10:00:00Z https://www.pharmexec.com/view/daily-fda-approves-beqalzi-inqovi2026-05-14T18:50:13.400Z2026-05-14T18:50:13.400Z https://www.pharmexec.com/view/transforming-clinical-trial-design-avoiding-ai-wrappers-angela-schwab2026-05-14T18:30:00Z2026-05-14T18:30:00Z https://www.pharmexec.com/view/why-75-top-pharma-execs-ditching-fragmented-marketing-stacks2026-05-14T16:55:13.449Z2026-05-14T16:55:13.449Z https://www.pharmexec.com/view/the-prior-authorization-system-fails-patients-there-s-a-better-way2026-05-14T16:00:00Z2026-05-14T16:00:00Z https://www.pharmexec.com/view/fda-approves-beqalzi-relapsed-refractory-mantle-cell-lymphoma-inqovi-combination-venetoclax2026-05-14T13:23:29.207Z2026-05-14T13:23:29.207Z https://www.pharmexec.com/view/molecule-competitive-battlefield-oncology2026-05-14T13:00:00Z2026-05-14T13:00:00Z https://www.pharmexec.com/view/25-years-lessons-learned-ketan-mehta2026-05-14T10:00:00Z2026-05-14T10:00:00Z https://www.pharmexec.com/view/misinformation-impacts-evidence-based-science2026-05-14T10:00:00Z2026-05-14T10:00:00Z https://www.pharmexec.com/view/why-e5-target-nobody-went-after2026-05-14T10:00:00Z2026-05-14T10:00:00Z https://www.pharmexec.com/view/daily-rigel-enters-exclusive-global-licensing-agreement-arvinas-pfizer-veppanu2026-05-13T18:26:42.278Z2026-05-13T18:26:42.278Z https://www.pharmexec.com/view/questions-you-couldnt-ask-time-how-agentic-ai-accelerates-market-entry2026-05-13T18:00:00Z2026-05-13T18:00:00Z https://www.pharmexec.com/view/being-an-expert-isnt-just-knowing-answers2026-05-13T14:00:00Z2026-05-13T14:00:00Z https://www.pharmexec.com/view/eli-lilly-foundayo-lower-dose-zepbound-helped-maintain-weight-loss-patients-switching-injectables2026-05-13T13:47:30.124Z2026-05-13T13:47:30.124Z https://www.pharmexec.com/view/rigel-enters-85-million-agreement-exclusive-global-rights-veppanu2026-05-13T13:21:12.661Z2026-05-13T13:21:12.661Z https://www.pharmexec.com/view/developing-new-therapies-across-multiple-regulatory-landscapes2026-05-13T10:00:00Z2026-05-13T10:00:00Z https://www.pharmexec.com/view/risks-conflating-science-politics2026-05-13T10:00:00Z2026-05-13T10:00:00Z https://www.pharmexec.com/view/marty-makary-steps-down-fda-commissioner-report2026-05-12T18:06:33.583Z2026-05-12T18:06:33.583Z https://www.pharmexec.com/view/boehringer-immunology-pipeline-preclinical-antibody-licensing2026-05-12T17:16:40.371Z2026-05-12T17:16:40.371Z https://www.pharmexec.com/view/bristol-myers-squibb-hengrui-pharma-form-15-2-billion-strategic-drug-development-collaboration2026-05-12T14:54:00Z2026-05-12T14:54:00Z https://www.pharmexec.com/view/global-leader-in-engagement-with-healthcare-stakeholders2026-05-12T13:55:47.795Z2026-05-12T13:55:47.795Z https://www.pharmexec.com/view/pharmaceutical-cybersecurityrisk-management-qa-jamie-singer-matt-flora2026-05-12T10:00:00Z2026-05-12T10:00:00Z https://www.pharmexec.com/view/insight-gap-biopharma-hidden-risk-race-against-patent-cliff2026-05-12T10:00:00Z2026-05-12T10:00:00Z https://www.pharmexec.com/view/optimizing-biopharma-commercial-strategy-patient-support-programs-qa-dean-erhardt2026-05-12T10:00:00Z2026-05-12T10:00:00Z https://www.pharmexec.com/view/maximizing-drug-impact2026-05-12T10:00:00Z2026-05-12T10:00:00Z https://www.pharmexec.com/view/consulting-venture-capital-gibb-witham-hack-the-box2026-05-12T10:00:00Z2026-05-12T10:00:00Z https://www.pharmexec.com/view/daily-gsk-enters-collaboration-support-launch-bepirovirsen2026-05-11T18:58:40.958Z2026-05-11T18:58:40.958Z https://www.pharmexec.com/view/fda-approves-bizengri-adults-nrg1-fusion-positive-cholangiocarcinoma2026-05-11T14:02:43.188Z2026-05-11T14:02:43.188Z https://www.pharmexec.com/view/gsk-enters-exclusive-collaboration-sbp-group-accelerate-bepirovirsen-launch-mainland-china2026-05-11T13:35:13.888Z2026-05-11T13:35:13.888Z https://www.pharmexec.com/view/adjusting-strategies-25-year-long-career2026-05-11T10:00:00Z2026-05-11T10:00:00Z https://www.pharmexec.com/view/president-trump-planning-fire-fda-commissioner-marty-makary-report2026-05-08T19:04:28.943Z2026-05-08T19:04:28.943Z https://www.pharmexec.com/view/daily-fda-extends-review-leqembi-sbla2026-05-08T17:51:49.773Z2026-05-08T17:51:49.773Z https://www.pharmexec.com/view/fda-extends-priority-review-leqembi-iqlik-subcutaneous-injection2026-05-08T14:04:51.832Z2026-05-08T14:04:51.832Z https://www.pharmexec.com/view/glp1-patent-expiry-rise-generics-transforming-drug-delivery-device-landscape-procurement-strategy2026-05-08T10:00:00Z2026-05-08T10:00:00Z https://www.pharmexec.com/view/factors-contributing-growth-radiopharmaceuticals-andrea-zobel-marco-hogenboom2026-05-08T10:00:00Z2026-05-08T10:00:00Z https://www.pharmexec.com/view/daily-angelini-pharma-acquires-catalyst-pharmaceuticals-4-billion-agreement2026-05-07T19:25:55.882Z2026-05-07T19:25:55.882Z https://www.pharmexec.com/view/incyte-announces-week-24-results-true-ad4-phase-iii-trial-opzelura2026-05-07T13:54:27.401Z2026-05-07T13:54:27.401Z https://www.pharmexec.com/view/angelini-enters-4-billion-agreement-acquire-catalyst2026-05-07T13:26:02.641Z2026-05-07T13:26:02.641Z https://www.pharmexec.com/view/strengthening-generic-drugs-supply-chain2026-05-07T10:00:00Z2026-05-07T10:00:00Z https://www.pharmexec.com/view/what-elements-conversation-about-bringing-manufacturing-home-missing2026-05-07T10:00:00Z2026-05-07T10:00:00Z https://www.pharmexec.com/view/winning-in-ai-overviews-protecting-brand-accuracy-in-ai-generated-answers2026-05-07T04:00:00Z2026-05-07T04:00:00Z https://www.pharmexec.com/view/daily-zentalis-doses-first-patient-azenosertib-phase-iii-trial2026-05-06T18:15:43.337Z2026-05-06T18:15:43.337Z https://www.pharmexec.com/view/first-patient-dosed-azenosertib-aspenova-phase-iii-trial-ovarian-cancer2026-05-06T14:04:18.038Z2026-05-06T14:04:18.038Z https://www.pharmexec.com/view/roundup-bayer-acquire-perfuse-therapeutics-madrigal-licensing-agreement-aro-pnpla32026-05-06T13:19:40.282Z2026-05-06T13:19:40.282Z https://www.pharmexec.com/view/the-past-present-and-future-innovation-of-cardinal-health-3pl-services-and-packaging-solutions2026-05-06T13:08:21.380Z2026-05-06T13:08:21.380Z https://www.pharmexec.com/view/navigating-sunshine-act-state-transparency-laws2026-05-06T12:00:00Z2026-05-06T12:00:00Z https://www.pharmexec.com/view/from-insight-impact-making-real-world-evidence-actionable-urology2026-05-06T10:00:00Z2026-05-06T10:00:00Z https://www.pharmexec.com/view/asembia-asx26-building-value-based-care-models-cell-gene-therapy-will-shrank2026-05-06T10:00:00Z2026-05-06T10:00:00Z https://www.pharmexec.com/view/daily-biontech-reports-2026-first-quarter-results2026-05-05T19:21:22.626Z2026-05-05T19:21:22.626Z https://www.pharmexec.com/view/fda-clears-investigational-new-drug-application-phase-ib-iia-trial-ck0802-steroid-refractory-graft-versus-host-disease2026-05-05T18:58:25.903Z2026-05-05T18:58:25.903Z https://www.pharmexec.com/view/how-to-overcome-supply-chain-constraints-and-enable-growth-for-cell-gene-therapies2026-05-05T15:07:43.348Z2026-05-05T15:07:43.348Z https://www.pharmexec.com/view/building-supplier-trust-transparency-and-cross-functional-collaboration-during-a-period-of-volatility2026-05-05T15:05:56.398Z2026-05-05T15:05:56.398Z https://www.pharmexec.com/view/biontech-releases-first-quarter-results-20262026-05-05T13:59:13.853Z2026-05-05T13:59:13.853Z https://www.pharmexec.com/view/death-deciling2026-05-05T10:00:00Z2026-05-05T10:00:00Z https://www.pharmexec.com/view/asembia-asx26-payers-embracing-value-based-care-models-cell-gene-therapies2026-05-05T10:00:00Z2026-05-05T10:00:00Z https://www.pharmexec.com/view/the-only-ai-simulation-built-for-life-sciences2026-05-04T19:50:17.965Z2026-05-04T19:50:17.965Z https://www.pharmexec.com/view/where-precision-meets-pressure-ai-roleplay-built-for-pharma-field-teams2026-05-04T19:49:36.646Z2026-05-04T19:49:36.646Z https://www.pharmexec.com/view/ebook-you-only-get-one-shot-at-launch-make-it-count-2026-05-04T19:40:00Z2026-05-04T19:40:00Z https://www.pharmexec.com/view/proving-coaching-roi-a-pharma-field-force-transformation2026-05-04T19:39:00Z2026-05-04T19:39:00Z https://www.pharmexec.com/view/launching-with-confidence-empowering-a-specialized-field-force-for-a-pediatric-formula2026-05-04T19:38:00Z2026-05-04T19:38:00Z https://www.pharmexec.com/view/ai-automation-101-for-field-excellence-in-life-sciences2026-05-04T19:37:00Z2026-05-04T19:37:00Z https://www.pharmexec.com/view/scaling-innovation-without-losing-executional-rigor-mark-thierer2026-05-04T18:54:54.027Z2026-05-04T18:54:54.027Z https://www.pharmexec.com/view/daily-ucb-acquire-candid-therapeutics2026-05-04T18:53:02.406Z2026-05-04T18:53:02.406Z https://www.pharmexec.com/view/ucb-enters-2-billion-agreement-acquire-candid-therapeutics2026-05-04T13:16:01.945Z2026-05-04T13:16:01.945Z https://www.pharmexec.com/view/shifting-landscape-making-affordable-dtp-scale-reality2026-05-04T10:00:00Z2026-05-04T10:00:00Z https://www.pharmexec.com/view/asembia-asx26-entirely-pass-through-business-model2026-05-04T10:00:00Z2026-05-04T10:00:00Z https://www.pharmexec.com/view/the-rwe-backlog-problem2026-05-04T04:50:00Z2026-05-04T04:50:00Z https://www.pharmexec.com/view/accelerating-early-rwe-exploration-without-increasing-analytic-burden2026-05-04T04:50:00Z2026-05-04T04:50:00Z https://www.pharmexec.com/view/validating-healthverity-exos-an-agentic-ai-platform-for-real-world-evidence2026-05-04T04:50:00Z2026-05-04T04:50:00Z https://www.pharmexec.com/view/daily-fda-approves-auvelity2026-05-01T19:13:14.573Z2026-05-01T19:13:14.573Z